Ranked #24 nationally and rated high-performing in lung cancer surgery, COPD and pneumonia.
Published in the Journal of the COPD Foundation, a multicenter safety study at UC Davis Health tested a protein drug (INBRX-101), developed to improve care for people with alpha-1 antitrypsin deficiency (AATD). The results show that INBRX-101 could provide relief for patients with far fewer infusions. This trial also sets the stage for a pivotal phase 2/3 trial, which will assess the drug’s efficacy and possibly lead to FDA approval.
The Comprehensive COPD Clinic at UC Davis Health has created the first remote patient monitoring program in the Sacramento region for high-risk patients with Chronic Obstructive Pulmonary Disease (COPD). Data collected is uploaded to a dashboard on the patient’s electronic health record and is monitored daily by respiratory therapists in the UC Davis Health Reversible Obstructive Airway Disease program.
In an NIH-funded study, UC Davis Health pulmonologists are exploring an innovative approach to determine whether statins may help treat obstructive airway diseases by delivering the medication via inhalation. The study’s principal investigator is Amir Zeki, M.D., professor of internal medicine specializing in pulmonary, critical care and sleep medicine at UC Davis Health. The team plans to expand its research with a Phase 1 and Phase 2 clinical trial to test the safety and efficacy of delivering statins by inhalation to treat asthma and COPD.
Division of Pulmonary, Critical Care and Sleep Medicine offers excellence in patient care, medical education, basic and clinical research and service to the community
Division of General Thoracic Surgery provides expansive services for the surgical treatment of non-cardiac benign and malignant diseases of the chest
The UC Davis Lung Cancer and Lung Nodule Early Detection (Lung-LEAD) Clinic is a specialized UC Davis Health service to detect and manage lung nodules and potential lung cancer
We welcome the opportunity to partner with you in caring for your patient.
Our specialists are available when the need arises. Learn more about a specific health specialty.
The goal of clinical studies at UC Davis Health is to discover and share knowledge to advance health.
A U.S. News & World Report best hospital in cancer, cardiology, heart & vascular surgery, diabetes & endocrinology, ENT, geriatrics, neurology & neurosurgery, orthopedics, and pulmonology & lung surgery.
Our team provides care for the most challenging cases, while harnessing research to advance and expand treatment options. Our specialists have expertise in treating advanced lung diseases, cystic fibrosis, asthma and more.
U.S. News & World Report rated UC Davis Medical Center high performing in lung cancer surgery.
U.S. News & World Report rated UC Davis Medical Center high performing in COPD treatment.
U.S. News & World Report rated UC Davis Medical Center high performing in pneumonia treatment.
One of ~56 U.S. cancer centers designated “comprehensive” by the National Cancer Institute.
UC Davis Medical Center received Healthgrades® America’s 100 Best Hospitals Award for 2024, placing us among the top 2% of hospitals nationwide for overall clinical performance. We also received accolades for high-quality patient care, known as Specialty Excellent Awards, in five areas including cardiac, neurosciences, gastrointestinal, critical care and pulmonary specialties.
UC Davis Medical Center has been recognized as one of the nation’s top hospitals by the 2023 edition of Becker’s Hospital Review’s “Great hospitals in America” list.
UC Davis Medical Center has received Magnet® recognition, the nation’s highest honor for nursing excellence.
Ranked Sacramento’s #1 hospital by U.S. News, and high-performing in back surgery, COPD, colon cancer surgery, gynecological cancer surgery, heart attack, heart failure, hip fracture, kidney failure, leukemia, lymphoma & myeloma, lung cancer surgery, pneumonia, prostate cancer surgery, stroke, TAVR, and gastroenterology & GI surgery.